MPL4 DRUSEN. A phase I study to establish the safety and efficacy of retinal pigment epithelium micropulse laser in subjects with high-risk drusen secondary to age-related macular degeneration 26/03/2013
Description
The objectives of this study are to evaluate the safety and efficacy of subthreshold micropulse on the retinal pigment epithelium in subjects with high-risk drusen secondary to age-related macular degeneration and to evaluate whether improvement in visual function occurs and whether progression to advanced stages of AMD is delayed.
Author
Dr Jordi Monés, médecin, titulaire d’un doctorat
Inscrit à l'ordre des médecins de Barcelone, sous le numéro 22838
Directeur
Docteur en médecine et chirurgie
Spécialiste en ophtalmologie
Spécialiste de la rétine, de la macula et du vitré
01/01/2015
FOVISTA: Clinical Trial for subfoveal neovascular age-related macular degeneration
19/03/2014
Clinical trial in antiretroviral-naive patients with choroidal neovascularization secondary to AMD
31/03/2014
Phase III Study of Lampalizumab in patients with geographic atrophy secondary to AMD
20/12/2014
MPL4 GA: A phase I study in subjects with geographic atrophy secondary to dry age-related macular degeneration
